Co-Authors
This is a "connection" page, showing publications co-authored by Romain Neugebauer and Carlos Iribarren.
Connection Strength
0.385
-
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
Score: 0.235
-
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Res Sq. 2023 Mar 22.
Score: 0.053
-
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
Score: 0.049
-
Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 Jan 13; JCO2101738.
Score: 0.049